PIDD Antibody
Product Specifications
Background
The protein encoded by this gene contains a leucine-rich repeat and a death domain. This protein has been shown to interact with other death domain proteins, such as Fas (TNFRSF6) -associated via death domain (FADD) and MAP-kinase activating death domain-containing protein (MADD), and thus may function as an adaptor protein in cell death-related signaling processes. The expression of the mouse counterpart of this gene has been found to be positively regulated by the tumor suppressor p53 and to induce cell apoptosis in response to DNA damage, which suggests a role for this gene as an effector of p53-dependent apoptosis. Alternative splicing results in multiple transcript variants.
NCBI Gene ID
55367
Swiss Prot
Q9HB75
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 1-85 of human PIDD (NP_665893.2) .
Clonality
Polyclonal
Conjugation
Unconjugated
Type
Primary Antibodies
Field of Research
Apoptosis, Cancer, Cell Cycle
Purification
Affinity purification
Positive Control
U-87MG
Concentration
Batch dependent
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Store at -20˚ C. Avoid freeze / thaw cycles.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=19-480
Calculated Molecular Weight
Observed: 100-110kDa
Fragment
IgG
Symbol
PIDD
Positive Control 2
293T
Positive Control 3
K-562
Positive Control 4
Mouse brain
Positive Control 5
Mouse liver
Positive Control 6
Mouse heart
NCBI Official Name
P53-induced death domain protein 1
NCBI Organism
Homo sapiens
Other Product Names
P53-induced Protein with a Death Domain; Leucine-rich Repeat and Death Domain-containing Protein; Lrdd
Tested Applications
WB, IF
Physical Properties
Liquid
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1074310-01 25 mg
(2-Bromo-4- ((2-chlorobenzyl) oxy) -5-methoxyphenyl) methanamine
Ask
View Details 
OR1074310-02 50 mg
(2-Bromo-4- ((2-chlorobenzyl) oxy) -5-methoxyphenyl) methanamine
Ask
View Details OR1074310-03 100 mg
(2-Bromo-4- ((2-chlorobenzyl) oxy) -5-methoxyphenyl) methanamine
Ask
View Details OR1074310-04 250 mg
(2-Bromo-4- ((2-chlorobenzyl) oxy) -5-methoxyphenyl) methanamine
Ask
View Details